Wednesday, June 10, 2026

pharma Β· Allergy Β· Allergic rhinoconjunctivitis

A. MENARINI MANUFACTURING

A. MENARINI MANUFACTURING clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Florence, IT HQ
122 Employees
EMA registrant Type
Company details
Status
Public
HQ
Florence, IT
Employees
122
Programs
2
Drugs
6
Patents
5
Intelligence Β· Clinical Programs

A. MENARINI MANUFACTURING projects

2 ClinicalTrials.gov programs sponsored by A. MENARINI MANUFACTURING.

A. MENARINI MANUFACTURING has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Bilaxten Flas 10 mg comprimidos bucodispersables

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergic rhinoconjunctivitis

    approved small molecule active

    1 trial
  2. Placebo for Allergy

    A. Menarini Industrie Farmaceutiche Riunite s.r.l.

    Allergy

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does A. MENARINI MANUFACTURING have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.